Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocotrienol in Advanced NSCLC
NCT02644252Phase 3Terminated
- Sponsor
- Vejle Hospital
- Start
- Jan 2016
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in non-small cell lung cancer (NSCLC), sponsored by Vejle Hospital. Started Jan 2016; status: terminated.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02644252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644252.